Literature DB >> 30792188

What the 2018 ASH venous thromboembolism guidelines omitted: nonadministration of pharmacologic prophylaxis in hospitalized patients.

Oluwafemi P Owodunni1, Brandyn D Lau2,3,4,5, Michael B Streiff4,6, Peggy S Kraus7, Deborah B Hobson1,8, Dauryne L Shaffer1,8, Kristen L W Webster1,4, Mujan Varasteh Kia1, Christine G Holzmueller1,4, Elliott R Haut1,4,5,9,10.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30792188      PMCID： PMC6391662          DOI： 10.1182/bloodadvances.2018030510

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  17 in total

1.  Preventability of Hospital-Acquired Venous Thromboembolism.

Authors:  Elliott R Haut; Brandyn D Lau; Peggy S Kraus; Deborah B Hobson; Bhunesh Maheshwari; Peter J Pronovost; Michael B Streiff
Journal:  JAMA Surg       Date:  2015-09       Impact factor: 14.766

2.  Surveillance bias in outcomes reporting.

Authors:  Elliott R Haut; Peter J Pronovost
Journal:  JAMA       Date:  2011-06-15       Impact factor: 56.272

3.  [What are the reasons for patient preference? A comparison between oral and subcutaneous administration].

Authors:  M Quante; I Thate-Waschke; M Schofer
Journal:  Z Orthop Unfall       Date:  2012-03-15       Impact factor: 0.923

4.  Evaluation of an institutional project to improve venous thromboembolism prevention.

Authors:  Christina A Minami; Anthony D Yang; Mila Ju; Eckford Culver; Kathryn Seifert; Lindsey Kreutzer; Terri Halverson; Kevin J O'Leary; Karl Y Bilimoria
Journal:  J Hosp Med       Date:  2016-12       Impact factor: 2.960

5.  Patient education program for venous thromboembolism prevention in hospitalized patients.

Authors:  Gregory Piazza; Thanh Nha Nguyen; Ruth Morrison; Deborah Cios; Benjamin Hohlfelder; John Fanikos; Marilyn D Paterno; Samuel Z Goldhaber
Journal:  Am J Med       Date:  2012-03       Impact factor: 4.965

6.  Nonadministration of medication doses for venous thromboembolism prophylaxis in a cohort of hospitalized patients.

Authors:  Victor O Popoola; Brandyn D Lau; Esther Tan; Dauryne L Shaffer; Peggy S Kraus; Norma E Farrow; Deborah B Hobson; Jonathan K Aboagye; Michael B Streiff; Elliott R Haut
Journal:  Am J Health Syst Pharm       Date:  2018-03-15       Impact factor: 2.637

7.  Adherence to pharmacological thromboprophylaxis orders in hospitalized patients.

Authors:  John Fanikos; Leslie Ann Stevens; Matthew Labreche; Gregory Piazza; Elaine Catapane; Lena Novack; Samuel Z Goldhaber
Journal:  Am J Med       Date:  2010-06       Impact factor: 4.965

8.  Patient preferences regarding pharmacologic venous thromboembolism prophylaxis.

Authors:  Adrian Wong; Peggy S Kraus; Brandyn D Lau; Michael B Streiff; Elliott R Haut; Deborah B Hobson; Kenneth M Shermock
Journal:  J Hosp Med       Date:  2014-11-22       Impact factor: 2.960

9.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients.

Authors:  Holger J Schünemann; Mary Cushman; Allison E Burnett; Susan R Kahn; Jan Beyer-Westendorf; Frederick A Spencer; Suely M Rezende; Neil A Zakai; Kenneth A Bauer; Francesco Dentali; Jill Lansing; Sara Balduzzi; Andrea Darzi; Gian Paolo Morgano; Ignacio Neumann; Robby Nieuwlaat; Juan J Yepes-Nuñez; Yuan Zhang; Wojtek Wiercioch
Journal:  Blood Adv       Date:  2018-11-27

10.  Effectiveness of two distinct web-based education tools for bedside nurses on medication administration practice for venous thromboembolism prevention: A randomized clinical trial.

Authors:  Brandyn D Lau; Dauryne L Shaffer; Deborah B Hobson; Gayane Yenokyan; Jiangxia Wang; Elizabeth A Sugar; Joseph K Canner; David Bongiovanni; Peggy S Kraus; Victor O Popoola; Hasan M Shihab; Norma E Farrow; Jonathan K Aboagye; Peter J Pronovost; Michael B Streiff; Elliott R Haut
Journal:  PLoS One       Date:  2017-08-16       Impact factor: 3.240
View more
  1 in total

Review 1.  New Paradigms of Extended Thromboprophylaxis in Medically Ill Patients.

Authors:  Kira MacDougall; Alex C Spyropoulos
Journal:  J Clin Med       Date:  2020-04-02       Impact factor: 4.241
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.